- Report
- March 2026
- 162 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 154 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 155 Pages
India
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
India
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 338 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 156 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 174 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 192 Pages
India
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 213 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 218 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 223 Pages
India
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 228 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 314 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 333 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 372 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 150 Pages
Germany
From €4377EUR$4,850USD£3,792GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more